[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Industry in United States 2017

April 2017 | 100 pages | ID: HDE9DC20668EN
Aruvian's R'search

US$ 875.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Health care in the United States is provided by many separate legal entities. Current estimates put US healthcare spending at approximately 15% of GDP, which is the highest in the world. The United States spends the highest percentage of health care costs on pharmaceuticals in the world. In the United States, around 85% of citizens have health insurance, either through their employer or purchased individually.

The federal government does not guarantee universal health care to all its citizens, but certain publicly-funded health care programs help to provide for some of the elderly, disabled, and the poor and federal law ensures public access to emergency services regardless of ability to pay. Those without health insurance coverage are expected to pay privately for medical services. Health insurance is expensive and medical bills are overwhelmingly the most common reason for personal bankruptcy in the United States.

This report from Aruvian Research on the Healthcare Industry in United States 2017 looks at the overall industry, starting with the basic market analysis, and leading on to analyzing the major issues facing the industry today. The report contains two Michael Porter’s Five Forces Analysis, and an industry analysis through the PEST framework. A look at the major players, growth drivers, the issue of GPOs in the healthcare industry, outsourcing trends, role of IT in the industry, and a lot more factors are looked at in this report.
A. EXECUTIVE SUMMARY

B. ANALYZING THE INDUSTRY

B.1 Defining the Market
B.2 Industry Segments
B.3 Industry Statistics
B.4 Investments in the Industry

C. GROWTH DRIVERS

D. BARRIERS TO INDUSTRY GROWTH

E. LOOKING AT THE HEALTHCARE WORKFORCE

E.1 Types of Jobs Available
E.2 Workforce Issues
E.3 Role of US Department of Labor

F. GROUP PURCHASING ORGANIZATIONS & THE HEALTHCARE INDUSTRY

F.1 Overview
F.2 Financial Burden of GPO Activities
F.3 Economic Impact of GPOs on the Healthcare Industry
F.4 Healthcare Group Purchasing Industry Initiative (HGPII)
F.5 Growth Trends of GPOs
F.6 Structure of GPOs

G. MICHAEL PORTER’S ANALYSIS OF GPOS IN THE HEALTHCARE INDUSTRY

G.1 Intra-Industry Competition
G.2 Oligopolistic Competition
G.3 Market Domination by GPOs
G.4 New Entrants & Threat of Competition
G.5 Bargaining Power of Suppliers & Buyers

H. MICHAEL PORTER’S ANALYSIS OF THE US HEALTHCARE INDUSTRY

H.1 Power of Suppliers & Buyers
H.2 Competition
H.3 Threat of New Entrants
H.4 Threat of Industry Substitution

I. HEALTH CARE INDUSTRY EVOLUTION AND THE ROLE OF INFORMATION TECHNOLOGY

J. OUTSOURCING TRENDS IN THE HEALTHCARE INDUSTRY

K. BUDGET CRISES AND THE IMPACT ON THE HEALTHCARE INDUSTRY

L. ANALYZING INDUSTRY GROWTH

M. LOOKING AT COMPETITION

N. US HEALTHCARE INDUSTRY: PEST FRAMEWORK

N.1 Political Features
N.2 Economic Features
N.3 Social Features
N.4 Technological Features

O. WASTE & EMISSIONS PROFILE OF THE US HEALTHCARE INDUSTRY

O.1 Biohazardous Waste
O.2 Hazardous Chemical Waste
O.3 Wastewater Discharge Data for the Healthcare Industry
O.4 Air Emissions from the Healthcare Industry
O.5 Municipal Solid Waste

P. ANALYSIS OF LEADING MARKET PLAYERS

P.1 3M Company
P.2 AmerisourceBergen Corporation
P.3 Bayer AG
P.4 Cardinal Health
P.5 Community Health Systems, Inc.
P.6 HCA Holdings, Inc.
P.7 Kimberly Clark Corporation
P.8 McKesson Corporation
P.9 Medline Industries, Inc.
P.10 Tenet Healthcare Corporation
P.11 Thermo Fisher Scientific Inc.
P.12 Universal Health Services, Inc.

Q. DIRECTIONS FOR INDUSTRY PLAYERS

R. INDUSTRY OUTLOOK

S. APPENDIX

T. GLOSSARY OF TERMS


More Publications